Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Vaccine|March 7, 2012
Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for antigen-specific cytotoxic T lymphocyte response stimulation under leukopenic conditionsLiliana Oliver, Audry Fernández, Judith Raymond, et al.Vaccine|August 23, 2005
Immunotherapy with CTL peptide and VSSP eradicated established human papillomavirus (HPV) type 16 E7-expressing tumorsIsis Torréns, Osmany Mendoza, Aileen Batte, et al.Journal for Immunotherapy of Cancer|May 16, 2014
Very small size proteoliposomes abrogate cross-presentation of tumor antigens by myeloid-derived suppressor cells and induce their differentiation to dendritic cellsAudry Fernández, Liliana Oliver, Rydell Alvarez, et al.International Immunology|March 4, 2008
Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells functionJoel de León, Audry Fernández, Marilyn Clavell, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 8, 2010
Inhibition of tumor-induced myeloid-derived suppressor cell function by a nanoparticulated adjuvantAudry Fernández, Circe Mesa, Ilaria Marigo, et al.Journal of Breast Cancer|June 3, 2022
Murine Mammary Carcinoma Induces Chronic Systemic Inflammation and Immunosuppression in BALB/c MiceDasha Fuentes, Alejandro Cabezas-Cruz, Circe Mesa, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Complete antitumor protection by perioperative immunization with GM3/VSSP vaccine in a preclinical mouse melanoma modelMariano R Gabri, Zaima Mazorra, Giselle V Ripoll, et al.Vaccine|April 17, 2009
Role of lipopolysaccharide in the induction of type I interferon-dependent cross-priming and IL-10 production in mice by meningococcal outer membrane vesiclesVanessa Durand, Joanne Mackenzie, Joel de Leon, et al.Oncoimmunology|September 14, 2020
A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapyAna Victoria Casadesús, Claire Deligne, Béré Kadjdiatou Diallo, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2023
A Bacterial and Ganglioside-based Nanoparticle Initiates Reprogramming of Macrophages and Promotes Antitumor PhenotypesRydell Alvarez-Arzola, Liliana Oliver, Michelle M Messmer, et al.Pageof 4